Are you Dr. Khemka?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 30 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
14200 W Celebrate Life Way
Goodyear, AZ 85338Phone+1 623-207-3000- Is this information wrong?
Summary
- Dr. Vivek Khemka, MD is an oncologist in Goodyear, Arizona. He is currently licensed to practice medicine in Arizona, Washington, and California.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
Zucker School of Medicine at Hofstra/NorthwellFellowship, Geriatric Medicine (Internal Medicine), 2003 - 2004
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2003
Wyckoff Heights Medical CenterInternship, Internal Medicine, 2000 - 2001
Sri Ramachandra Medical CollegeClass of 1993
Certifications & Licensure
WA State Medical License 2011 - 2025
NY State Medical License 2003 - 2024
CA State Medical License 2011 - 2024
AZ State Medical License 2008 - 2024
NJ State Medical License 2005 - 2009- American Board of Internal Medicine Medical Oncology
- National Board of Physicians and Surgeons Geriatric Medicine
- National Board of Physicians and Surgeons Hospice and Palliative Medicine
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Publications & Presentations
PubMed
- 7 citationsCorrection to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J. Weiss, Lisa Blaydorn, Julia Beck, Kirsten Bornemann-Kolatzki, Howard B. Urnovitz, E. Schütz, Vivek Khemka> ;Investigational New Drugs. 2019 Apr 24
- 128 citationsPhase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J. Weiss, Lisa Blaydorn, Julia Beck, Kirsten Bornemann-Kolatzki, Howard B. Urnovitz, E. Schütz, Vivek Khemka> ;Investigational New Drugs. 2018 Feb 1
- 109 citationsTumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to ImmunotherapyGlen J. Weiss, Julia Beck, Donald P Braun, Kristen Bornemann-Kolatzki, Heather Barilla, Rhiannon Cubello, Walter Quan, Ashish Sangal, Vivek Khemka, Jordan Waypa, Willi...> ;Clinical Cancer Research. 2017 Sep 1
- Join now to see all
Press Mentions
CTCA at Western Regional Medical Center Advances Combination Immunotherapy Clinical TrialJanuary 8th, 2016
Clinical Trial Using Immunotherapy Drug Combinations to Treat Lung Cancer Appears SafeSeptember 9th, 2015
CTCA Initiates New Clinical Study of Immunotherapy Combined with ChemotherapyJuly 1st, 2015
Professional Memberships
- Member
- Member
